Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy Laura Testa; Max Mano; Roberto Jun Arai; Renata Colombo Bonadio; Sergio V. Serrano; Marina M Costa Zorzetto; Susanne Crocamo; Oren Smaletz; Ruffo Freitas-Junior; Paulo M. Hoff;

Comparative efficacy & safety of buparlisib plus fulvestrant, fulvestrant plus dalpiciclib, and ribociclib plus letrozole for postmenopausal, hormone receptor-positive, and HER2-negative breast cancer Qi Liu; Lingli Hou; Ying Zhao; Hongwei Yang; Zhengying Mo; Fei Yu;

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non¿small¿cell lung cancer: A meta analysis Min Yi; Ting He; Kaijin Wang; Yonggang Wei;